Home
/

What is an MCH Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

MCH measures the average amount of hemoglobin—the oxygen-carrying protein—in each red blood cell, typically 27–33 pg. Low MCH is associated with iron deficiency or thalassemia, causing fatigue and breathlessness, while high MCH reflects larger cells from B12/folate deficiency or thyroid issues. MCH is most informative alongside hemoglobin, MCV, ferritin, and B12/folate levels.

Read more →
Table of contents

MCH: How Much Hemoglobin Each Red Cell Carries

Mean Corpuscular Hemoglobin (MCH) is the average amount of hemoglobin contained in each red blood cell. Hemoglobin is the iron-bearing protein that binds oxygen in the lungs and releases it to tissues. Red blood cells are formed in the bone marrow, where hemoglobin is packed into them as they mature. MCH is reported as part of a routine complete blood count (CBC), summarizing, across millions of cells, how much hemoglobin an individual red cell carries on average.

The hemoglobin content per cell sets the oxygen-carrying capacity of that cell. MCH therefore reflects how richly each red blood cell is loaded with hemoglobin (hemoglobinization) and, by extension, the potential efficiency of oxygen delivery to organs. It captures the result of hemoglobin production in the marrow—driven by iron supply and globin synthesis—and the size of the red cell that receives it. In plain terms, MCH tells you how many oxygen-binding sites are available on an average red cell, a core feature that supports normal energy use throughout the body (aerobic metabolism).

Why Per-Cell Hemoglobin Matters for Oxygen Delivery

Mean Corpuscular Hemoglobin (MCH) measures how much hemoglobin—the oxygen-carrying protein—is packed into each red blood cell. It's a window into whole-body oxygen delivery: when each cell carries the right load, your brain, heart, and muscles run efficiently; when it doesn't, energy, cognition, and endurance slip.

Because hemoglobin carries oxygen, MCH reflects the cell-by-cell capacity to deliver oxygen to tissues that power energy production, brain function, muscle performance, heart work, fertility, and immune defenses.

Reading Low (Hypochromic), Mid-Range, and High (Macrocytic) MCH

Typical MCH falls around 27–33, and the physiologic "sweet spot" tends to sit near the middle, in harmony with cell size (MCV) and concentration (MCHC). Values outside this band point toward issues with iron, B12/folate, inflammation, liver or thyroid function, alcohol effects, or bone marrow production.

When MCH runs low, each cell brings less hemoglobin to the tissues—most often from iron deficiency, thalassemia traits, or chronic inflammatory states. The result is less oxygen per heartbeat, with fatigue, breathlessness on exertion, palpitations, headaches, pale skin, brittle nails, and exercise intolerance. The heart compensates by working harder; attention and mood can waver. Women with heavy menstrual loss and people who are pregnant are especially susceptible; in children and teens, low MCH can relate to learning, attention, or growth concerns.

Low values usually reflect too little hemoglobin per cell (hypochromia), often alongside small cells (microcytosis). This pattern most commonly signals iron lack or chronic blood loss, but can also arise from impaired iron use in inflammation, thalassemia traits, or rarer problems in heme synthesis. The system-level impact is reduced oxygen delivery: fatigue, reduced exercise tolerance, shortness of breath, palpitations, and cognitive fog. Children, people who menstruate, and pregnancy have higher risk because iron demand is high.

Being in range suggests adequate iron supply and intact heme synthesis, with red cells appropriately hemoglobinized for their size. This supports steady oxygen delivery, more stable energy and cognition, and less cardiovascular strain. In most labs, a mid-range and consistent MCH over time is considered within reference ranges.

When MCH trends high, red cells are typically larger and hemoglobin-rich, as seen with B12 or folate deficiency, alcohol-related liver disease, hypothyroidism, certain medicines, or marrow disorders. Even with more hemoglobin per cell, fewer cells can yield anemia—fatigue persists, and numbness, imbalance, or memory changes suggest B12 involvement; glossitis and easy bruising may appear.

High values usually reflect larger cells carrying more hemoglobin per cell (macrocytosis). Common causes include low vitamin B12 or folate, alcohol-related or liver disease, hypothyroidism, some medications, marrow disorders, or increased young cells (reticulocytosis). Despite higher per-cell hemoglobin, total oxygen delivery may fall if anemia is present; B12 deficiency may add neurologic symptoms.

What Can Artifactually Shift MCH

Interpret MCH with MCV, MCHC, RDW, hemoglobin, and RBC count. Newborns have higher MCH; pregnancy and infancy use different reference ranges. Recent transfusion, marked lipemia, or cold agglutinins can artifactually raise indices.

Big picture: MCH integrates nutrient status, marrow health, and oxygen transport. Read alongside hemoglobin, MCV, MCHC, RDW, and ferritin, it clarifies whether anemia is iron-restricted, macrocytic, inflammatory, or marrow-related—patterns linked to cardiovascular strain, pregnancy outcomes, neurocognitive health, and long-term vitality.

FAQs

MCH is the average hemoglobin content per red blood cell, reported in picograms and derived from the complete blood count.

Low MCH indicates hypochromic red cells, often from iron deficiency, thalassemia traits, or chronic disease.

High MCH reflects macrocytic cells, often due to B12 or folate deficiency, and may also result from liver disease, alcohol use, hypothyroidism, or medications.

MCH is calculated from hemoglobin and red blood cell count on the CBC, showing the hemoglobin content per cell.

No. MCH is part of the CBC and does not require fasting.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Buttarello, M. (2016). Laboratory diagnosis of anemia: Are the old and new red cell parameters useful in classification and treatment, how? International Journal of Laboratory Hematology, 38(S1), 123-132. https://doi.org/10.1111/ijlh.12500
  2. Schop, A., Stouten, K., Riedl, J. A., van Houten, R. J., Leening, M. J. G., Bindels, P. J. E., & Levin, M. D. (2021). The accuracy of mean corpuscular volume guided anaemia classification in primary care. Family Practice, 38(6), 735-739. https://doi.org/10.1093/fampra/cmab034
  3. Kaferle, J., & Strzoda, C. E. (2009). Evaluation of macrocytosis. American Family Physician, 79(3), 203-208. https://pubmed.ncbi.nlm.nih.gov/19202968/
  4. Ali, N. T. (2025). Mean corpuscular volume (MCV) and mean platelet volume (MPV) as early diagnostic markers for preeclampsia, gestational diabetes, and anemia: A systematic review of clinical evidence and mechanisms. BMC Pregnancy and Childbirth, 25(1), 722. https://doi.org/10.1186/s12884-025-07802-x
  5. Seo, I. H., & Lee, Y. J. (2022). Usefulness of complete blood count (CBC) to assess cardiovascular and metabolic diseases in clinical settings: A comprehensive literature review. Biomedicines, 10(11), 2697. https://doi.org/10.3390/biomedicines10112697

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey